Patent: 10,570,103
✉ Email this page to a colleague
Summary for Patent: 10,570,103
Title: | Heterocyclic compounds useful in the treatment of disease |
Abstract: | A method for treating a lysophosphatidic acid-dependent disease or condition in a subject in need thereof is provided. The method includes administering to the subject a therapeutically effective amount of a heterocyclic compound. The heterocyclic compound is a lysophosphatidic acid receptor ligand. Lysophosphatidic acid-dependent diseases and conditions include diseases involving fibrosis, such as fibrosis of the heart, kidney, liver and lung, and scleroderma; inflammatory diseases such as diabetic nephropathy and inflammatory bowel disease; ocular diseases such as diseases involving retinal degeneration; nerve diseases such as pruritus and pain. |
Inventor(s): | Beaton; Graham (San Diego, CA), Tucci; Fabio C. (San Diego, CA), Ravula; Satheesh B. (San Diego, CA), Shah; Chandravadan R. (San Diego, CA), Luu; Hiep (San Marcos, CA) |
Assignee: | EPIGEN BIOSCIENCES, INC. (San Diego, CA) |
Application Number: | 16/000,283 |
Patent Claims: | see list of patent claims |
Details for Patent 10,570,103
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2033-03-15 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2033-03-15 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2033-03-15 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2033-03-15 | |
Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | 06/04/1986 | ⤷ Try a Trial | 2033-03-15 |
Hemispherx Biopharma, Inc. | ALFERON N INJECTION | interferon alfa-n3 (human leukocyte derived) | Injection | 103158 | 10/10/1989 | ⤷ Try a Trial | 2033-03-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |